ARCHIVES

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Response Oncology Sells Practice Back To Physicians.

March 2, 2001

Cancer Meetings Listed

March 26, 1993

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

March 4, 1988

House Members Express Support for Cancer Program

September 12, 1980

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984